HB 1099
Signed
reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.
- South Dakota
- House / Assembly
- Introduced Jan 21, 2026
- Session 2026
Official Bill Page
Loading official bill page…
This state’s bills aren’t available here
South Dakota’s legislature doesn’t allow its bill pages to be shown on other sites. You can read the full bill on the official page.
View on official siteLegislative Timeline
14 actions-
Signed by the Governor on 2026-03-10 H.J. 547
-
Delivered to the Governor on 2026-03-05 H.J. 520
-
Signed by the President S.J. 470
-
Signed by the Speaker H.J. 492
-
Senate Do Pass , Passed, YEAS 21, NAYS 12 S.J. 429
-
Remove from Consent Calendar S.J. 412
-
Certified uncontested, placed on consent , Passed, S.J. 21
-
Health and Human Services Do Pass , Passed, YEAS 6, NAYS 0 S.J. 21
-
Scheduled for hearing S.J. 1
-
First read in Senate and referred to Senate Health and Human Services S.J. 232
-
House of Representatives Do Pass , Passed, YEAS 58, NAYS 7 H.J. 265
-
Health and Human Services Do Pass , Passed, YEAS 13, NAYS 0 H.J. 13
-
Scheduled for hearing H.J. 1
-
First read in House and referred to House Health and Human Services H.J. 104